TrialThe Journal of infectious diseases2022

Impact of Preexisting Anti-Adenovirus 26 Humoral Immunity on Immunogenicity of the Ad26.COV2.S Coronavirus Disease 2019 Vaccine.

Mathieu Le Gars et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.